RBOT (STOCKS)
VICARIOUS SRGCL INC A
$0.780000
+0.080000 (+11.43%)
Prev close: $0.700000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Adam Sachs
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $137.58M
- Employees
- 131
- P/E (TTM)
- -22.11
- P/B (TTM)
- 0.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.57 | $-1.40 | -0.1726 | -12.35% |
|
Sep 2025 (Q3)
|
$-1.86 | $-2.37 | +0.5132 | +21.62% |
|
Jun 2025 (Q2)
|
$-2.23 | $-2.55 | +0.3166 | +12.43% |
|
Mar 2025 (Q1)
|
$-2.60 | $-2.53 | -0.0704 | -2.78% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$155.00K |
| Operating Expenses | $50.03M |
| Research and Development | $33.60M |
| Other Operating Expenses | $16.43M |
| Operating Income/Loss | -$50.03M |
| Income/Loss From Continuing Operations After Tax | -$50.18M |
| Income/Loss From Continuing Operations Before Tax | -$50.18M |
| Net Income/Loss | -$50.18M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$50.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 6,130,652 |
| Diluted Average Shares | 6,130,652 |
| Assets | $19.58M |
| Current Assets | $11.58M |
| Cash | $9.79M |
| Other Current Assets | $1.79M |
| Noncurrent Assets | $8.00M |
| Fixed Assets | $1.27M |
| Other Non-current Assets | $6.73M |
| Liabilities | $9.74M |
| Current Liabilities | $3.90M |
| Accounts Payable | $894.00K |
| Wages | $501.00K |
| Other Current Liabilities | $2.51M |
| Noncurrent Liabilities | $5.84M |
| Equity | $9.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.84M |
| Liabilities And Equity | $19.58M |
| Net Cash Flow From Operating Activities | -$45.08M |
| Net Cash Flow From Operating Activities, Continuing | -$45.08M |
| Net Cash Flow From Investing Activities | $32.15M |
| Net Cash Flow From Investing Activities, Continuing | $32.15M |
| Net Cash Flow From Financing Activities | $5.76M |
| Net Cash Flow From Financing Activities, Continuing | $5.76M |
| Net Cash Flow | -$7.17M |
| Net Cash Flow, Continuing | -$7.17M |
| Comprehensive Income/Loss | -$50.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.23M |
| Other Comprehensive Income/Loss | -$46.00K |